Loading stock data…
PRGO
$11.92+0.08 (+0.68%)
Market ClosedLast close May 1
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Perrigo Company plc in the Healthcare sector is trading at $11.92. The stock is currently near its 52-week low of $9.23, remaining 27.7% below its 200-day moving average. Technical signals show neutral RSI of 61 and bullish MACD crossover, explaining why PRGO maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 61) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$11.92
Potential Upside
5%
Whystock Fair Value$12.52
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus4 analysts
Buy
Mean target$17.00+42.6%
Range$15.00 – $20.00
Fundamentals
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper res...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.63B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.49
Div Yield
Strong income play. Yield provides a meaningful total return floor.
981.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-2.73%
Volume
Today's trading volume
1.30M
Recent News
ICU Medical (ICUI) Reports Next Week: Wall Street Expects Earnings Growth
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for
Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Healthcare Stocks Paying the Highest Dividends in the Sector Right Now
The highest-yielding healthcare stocks come with some side effects.
Is Perrigo (PRGO) Offering Value After A 49.9% One Year Share Price Decline?
Before looking at detailed valuation models, it helps to ask a simple question: is Perrigo's current share price of US$11.82 offering you real value or just reflecting recent sentiment swings? Over the past week the stock return was 0.2%, over the past month it was 24.0%, yet year to date the return was a 14.9% decline and over the last year the return was a 49.9% decline. Together, these figures give you a mixed picture of momentum and risk perceptions. Recent news around Perrigo has largely...
Perrigo (PRGO) Positioned for Growth Amid Market Challenges
Perrigo Company plc (NYSE:PRGO) is among the best small-cap value stocks to buy according to analysts. On March 11, 2026, Perrigo Company PLC (NYSE:PRGO) presented at the UBS Global Consumer and Retail Conference, where CEO Patrick Lockwood‑Taylor discussed the company’s strategy to focus on core businesses and strengthen retailer partnerships. Despite a soft market environment, […]